Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082431 · ClinicalTrials.gov registry record
Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 600
- Enrollment target
NCT02082431: Completed study, sponsored by Pediatrix.
NCT02082431 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02082431 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the true incidence of long QT (LQT) amongst a large cohort of subjects diagnosed with unilateral (right/left) or bilateral sensorineural hearing loss.
Primary Outcome
ECG results to determine QTc length
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2014-08 |
| Est. Completion | 2020-07-20 |
What the finished NCT02082431 record still lists
NCT02082431 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02082431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02082431 about?
NCT02082431 is a clinical study titled "Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.". The purpose of this study is to determine the true incidence of long QT (LQT) amongst a large cohort of subjects diagnosed with unilateral (right/left) or bilateral sensorineural hearing loss.
What is the current status of trial NCT02082431?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2014-08. Estimated completion is 2020-07-20.
Who is sponsoring clinical trial NCT02082431?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia